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Ambivalent Nucleophilicity of 1,4,5-Trisubstituted
Imidazole-2-thiones in Reactions with Dimethyl
Acetylenedicarboxylate and Phenylisocyanate
Abstract
The 1,4,5-trisubstitued 2,3-dihydro-1H-imidazole-2-thiones 1 react with electrophilic reagents via the S-
or the N(3)-atom. The reaction with dimethyl acetylenedicarboxylate in methanol at room temperature
occurs by the nucleophilic addition of the S-atom to give the corresponding
2-[(1H-imidazol-2-yl)sulfanyl]fumarates 4 in high yield. On the other hand, imidazole-2-thiones 1 react
with phenylisocyanate in dichloromethane at room temperature to yield
2,3-dihydro-2-thioxo-1H-imidazole-1-carboxamides 5. The structures of both types of adducts were
established by X-ray crystallography.
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The 1,4,5-trisubstitued 2,3-dihydro-1H-imidazole-2-thiones 1 re act with electrophilic
re agents via the S- or the N(3)-atom. The re ac tion with dimethyl acetylenedicarboxylate
in meth a nol at room tem per a ture oc curs by the nucleophilic ad di tion of the S-atom to give 
the cor re spond ing 2-[(1H-imidazol-2-yl)sulfanyl]fumarates 4 in high yield. On the other
hand, imidazole-2-thiones 1 re act with phenylisocyanate in di chloro methane at room
tem per a ture to yield 2,3-dihydro-2-thioxo-1H-imidazole-1-carboxamides 5. The struc -
tures of both types of ad ducts were es tab lished by X-ray crys tal log ra phy.
Key words: imidazole-2-thiones, addition reactions, acetylenedicarboxylates, iso cyanates,
X-ray crystallog ra phy
The chem is try of imidazole-2-thiones was re viewed by Trzhtsinskaya and
Abramova in 1991 [1]. In ad di tion to well-known pro ce dures for the prep a ra tion of
dif fer ently sub sti tuted imidazole-2-thiones pre sented in [1], we re ported a smooth
con ver sion of 2-unsubstituted imidazole 3-ox ides via a sul fur-trans fer re ac tion by
treat ment with 2,2,4,4-tetramethyl-3-thioxocyclobutanone at room tem per a ture. The 
start ing ma te ri als are eas ily avail able by con den sa tion of a-hydroxyiminoketones
with pri mary amines and form al de hyde [2–4]. Many rep re sen ta tives of imid -
azole-2-thiones are of in ter est due to their bi o log i cal ac tiv ity [5] and pos si ble ap pli -
ca tions in the syn the sis of more com plex mol e cules con tain ing the imidazole ring [6]. 
As a re sult of the pres ence of  N- and S-at oms, imidazole-2-thiones are con sid ered as
‘ambifunctional’ nucleophilic agents [1].
Whereas al ky la tions, arylations and acylations of imidazole-2-thiones are well
known [1], re ac tions with ac ti vated al kynes and heterocumulenes are rarely re ported. 
The par ent imidazole-2-thione (1a) upon treat ment with dimethyl acetylene di -
carboxylate (DMAD) gave the 4H-imidazo[2,1-b][1,3]thiazine-2-carboxylate 2 in a
two-step re ac tion [7] (Scheme 1). The re ac tion mech a nism in volves a Mi chael ad di -
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tion via the S-atom as the ini ti at ing step fol lowed by the ring clo sure via elim i na tion
of meth a nol*.
Re ac tions of 1-methylimidazole-2-thione with DMAD were stud ied in the pres -
ence of triphenylphosphane [8]. In this sys tem, the first re ac tion step is the
nucleophilic ad di tion of Ph3P onto DMAD lead ing to the Mitsunobu type in ter me di -
ate [9]. Protonation of the lat ter and nucleophilic ad di tion of the imidazole-2-thiolate
yields the iso lated prod uct 3 (Scheme 2).
To the best of our knowl edge, there are no re ports avail able de scrib ing re ac tions
of imidazole-2-thiones with ei ther isocyanates or isothiocyanates. In the pres ent pa -
per, we de scribe the re ac tions of 1,4,5-trisubstituted imidazole-2-thiones with
DMAD and phenyl isocyanate.
RE SULTS AND DIS CUS SION
Methanolic so lu tions of equimolar amounts of imidazole-2-thiones 1c–f and
DMAD were stirred at room tem per a ture, and af ter 24 h, the TLC con trol showed
com plete con ver sion of the start ing ma te ri als. In the case of  1c, a sin gle prod uct was
formed, which ten ta tively was iden ti fied as the [(imidazol-2-yl)sulfanyl]fumarate
(4a) (Scheme 3).
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*  In a comparable reaction, 4,5-diphenylimidazole-2-thione and phenylacetylene carbonitrile yielded an
  imidazo[2,3-b][1,3]-thiazin-2-imine [10]. In this reaction, the first adduct is formed by a Michael addition
  via the N-atom of the imidazole ring and subsequent ring closure via the attack of the S-atom onto the cyano
 group.  
The struc ture de ter mi na tion was based on the com par i son of the 1H- and
13C-NMR data of 1c with those given in the lit er a ture. Firstly, the 13C sig nal of C(2)
in 1c ap pears at 160.1 ppm [11] and dif fers sig nif i cantly from the value found for C(2) 
of the imidazole ring in 4a (136.1 ppm). For this rea son we pro pose that the prod uct is
formed via the Mi chael at tack of the S-atom onto DMAD. Sec ondly, the as sign ment
of the trans-ori en ta tion of the es ter groups is sup ported by the com par i son of the
1H-NMR ab sorp tion of the MeO groups in 4a  with those of dimethyl
(phenylsulfanyl)fumarate. Ac cord ing to [12], the sig nals of the lat ter ap pear at 3.75
and 3.29 ppm, whereas in the iso meric maleate only one sig nal at 3.58 ppm is re -
ported. The ab sorp tions in 4a were found at 3.74 and 3.58 ppm, which fit better with
the pat tern of the fumarate. The spec tro scopic data of prod ucts 4b–d, which also were 
formed as sin gle prod ucts, were com pa ra ble with those of 4a and, there fore, anal o -
gous struc tures were at trib uted to these ad ducts. Fi nally, the struc ture of 4d was un -
am big u ously es tab lished by X-ray crys tal log ra phy (Fig ure 1).
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Fig ure 1. ORTEP plot [13] of one of the two sym me try-in de pend ent mol e cules of 4d (with 50% prob a -
bil ity el lip soids; ar bi trary num ber ing of the at oms).
So lu tions of imidazole-2-thiones 1c,g,h in di chloro methane were treated with
phenylisocyanate at room tem per a ture. Af ter 24 h, the sol vent was evap o rated and
sta ble crys tal line prod ucts were iso lated in good yields. In the 1H-NMR spec trum of
the prod uct ob tained from 1c, two singlets for Me groups at 2.43 and 1.99 ppm, a sin glet
for the benzylic CH2 group at 5.39 ppm, and a multiplet for two Ph res i dues be tween 7.66
and 7.11 ppm ap peared. The 13C-NMR spec trum showed the cor re spond ing ab sorp tions
and two singlets at 161.7 and 148.7 ppm. These sig nals can be as cribed to the C=S and 
C=O group in struc ture 5a (as men tioned above, C=S of 1c ab sorbs at 160.1 ppm)
(Scheme 4). How ever, they also could be at trib uted to C(2) of the imidazole ring and
C=O in the iso meric struc ture of type 6. There are no rel e vant spec tro scopic data
avail able for urea de riv a tives of type 5* and only very few for thiocarbonyl de riv a -
tives of type 6**. For this rea son, an un am big u ous de ci sion be tween struc tures 5 and 6
was not pos si ble.
Con sid er ing the re sults of the re ac tion of benzimidazole-2-thione with iso -
cyanates, which gave the N-carbamoyl de riv a tive and not the iso meric thio carbamate 
[14b], we pro posed the struc ture 5 for the prod uct of the re ac tion of 1 with phenyl -
isocyanate***. In or der to prove the struc ture of the adduct 5b, a crys tal-struc ture de -
ter mi na tion was per formed (Fig ure 2). The NH group forms an intramolecular
hy dro gen-bond with the S-atom to give a six-membered loop which can be de scribed
by a graph set mo tif [16] of S(6).
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*    However, the 13C-NMR data for 2-thioxo-2,3-dihydroimidazole-1-carboxylic acid cyclohexylamide
   are known [14a]. They fit well with those found for C=S and C=O absorptions in the series 5a–c.
**   In recent papers, the synthesis and spectroscopic properties of some S-alkyl N-phenylthiocarbamates
   were reported The chemical shift for C=O is given at ca. 165 ppm [14].
***   In con trast to the la bile ad ducts de scribed in [15], prod ucts 5 were sta ble, could be recrystallized, and
   melted with out de com po si tion. 
The at tempted re ac tions of 1c with the less re ac tive phenylisothiocyanate un der
anal o gous con di tions failed.
CON CLU SIONS
The 1,4,5-trisubstituted imidazole-2-thiones 1 re act smoothly with both DMAD
and phenylisocyanate to give 1:1-ad ducts in both cases. The struc tures es tab lished
for the prod ucts of these re ac tions con firm the am biv a lent nucleophilic char ac ter of
1. Whereas in the re ac tion with DMAD, the re ac tive cen ter of 1 is the S-atom, the ad -
di tion to the isocyanate oc curs via at tack of the N-atom of the imidazole. To the best
of our knowl edge, this is the first study in which the am biv a lent nucleophilicity of
imidazole-2-thiones is ev i denced. On the other hand, in the case of the re ac tion with
phenylisocyanate, a multistep mech a nism via at tack of the S-atom of 1 onto the
electrophile to give 6 can not be ex cluded. A sub se quent 1,3-shift of the carbamoyl
group would lead to the iso lated prod uct 5. It is worth men tion ing that in the case of
benzimidazole-2-thione (and also pu rine-8-thione) the alkylation with 4-nitrobenzyl
bro mide oc curs at the S-atom whereas the acylation with ethyl chloroformate leads to
the carbamate (N-sub sti tu tion) [17]. The Mi chael ad di tion with DMAD is a stereo -
selective pro cess and leads to the ‘fumarate de riv a tive’ (Z-iso mer) only.
Am biv a lent nucleophilicity of 1,4,5-trisubstituted... 1565
 
Fig ure 2. ORTEP plot [13] of the mo lec u lar struc ture of 5b (with 50% prob a bil ity el lip soids; ar bi trary
num ber ing of the at oms).
EX PER I MEN TAL
1. Gen eral. M. p.’s were de ter mined in cap il lar ies (Melt-Temp. II, Aldrich); un cor rected. IR spec tra:
NEXUS FT-IR spectrophotometer; in KBr. 1H- and 13C-NMR spec tra: Tesla BS567A (80 and 20 MHz,
resp.) or Bruker AC 300 in stru ment (300 and 75.5 MHz, resp.), in CDCl3; TMS as an in ter nal stan dard.
The mul ti plic ity of the 13C sig nals was de duced from DEPT spec tra. MS: Finnigan MAT-90 or Finnigan
SSQ-700 in stru ments (CI (NH3)).
2. Start ing ma te ri als. Dimethyl acetylenedicarboxylate (DMAD) and phenylisocyanate are com -
mer cially avail able and both re agents were freshly dis tilled prior to their use. Imidazole-2-thiones 1c–h
are eas ily avail able by a ‘sul fur trans fer’ re ac tion from the cor re spond ing imidazole 3-ox ides and
2,2,4,4-tetramethylcyclobutane-1,3-dithione ac cord ing to the pub lished pro to col [11].
3. Re ac tions of imidazole-2-thiones 1c–f with dimethyl acetylenedicarboxylate (DMAD). Gen -
eral pro ce dure. To a mag net i cally stirred so lu tion con tain ing DMAD (284 mg, 2 mmole) dis solved in
meth a nol (4 ml), an equimolar amount of the cor re spond ing imidazole-2-thione 2 was added in small por -
tions at room tem per a ture. When the ad di tion was com plete, stir ring was con tin ued for 1 h. Then, the sol vent 
was evap o rated to dry ness. Crude prod ucts were pu ri fied by crys tal li za tion from isopropanol at room tem -
per a ture.
(Z)-2-[(1-Benzyl-4,5-dimethyl-1H-imidazol-2-yl)sulfanyl]but-2-enedioic acid dimethyl es ter (4a).
Yield: 610 mg (85%). Yel low crys tals, m.p. 130–132°C. IR (KBr): 2950m, 2920m, 22360m, 2340m,
1730vs (C=O), 1710vs (C=O), 1600m, 1440s, 1410s, 1320s, 1250vs, 1200vs, 1180s, 1020vs, 720s.
1H-NMR: 7.29–7.05 (m, 5 arom. CH); 6.45 (s, C=CH); 5.23 (s, CH2); 3.74, 3.58 (2s, 2 MeO); 2.14, 2.02 (2s, 
2 Me). 13C-NMR: 165.2, 164.2 (2s, 2 CO); 147.0 (s, C=CH); 136.2, 136.1, 133.6 (3s, 3 imidazole Cq, 1
arom. Cq); 128.7, 127.5, 126.9 (3d, 5 arom. CH); 119.8 (d, C=CH); 52.9, 51.8 (2q, 2 MeO); 48.4 (t, CH2);
12.7, 9.4 (2q, 2 Me). CI-MS (m/z): 361 (100, [M+l]+). Anal. Calcd for C18H20N2O4S (360.29): C 60.00, H
5.56, N 7.76; found: C 59.96, H 5.40, N 7.80.
(Z)-2-[(1-Benzyl-4,5-di phen yl-1H-imidazol-2-yl)sulfanyl]but-2-enedioic acid dimethyl es ter (4b).
Yield: 840 mg (87%). Yel low crys tals, m.p. 127–129°C. IR (KBr): 1730vs (C=O), 1710vs (C=O), 1605m,
1595m, 1440s, 1315m, 1245s, 1200s, 1180s, 1050m, 780m, 700s. 1H-NMR: 7.51–6.84 (m, 15 arom. H);
6.58 (s, C=CH); 5.15 (s, CH2); 3.75, 3.59 (2s, 2 MeO). 13C-NMR: 165.3, 164.5 (2s, 2 CO); 146.5 (s,
C=CH); 139.6 (s, imidazole Cq); 137.6, 136.5, 136.2 (3s, 3 arom. Cq); 130.4 (2s, 2 imidazole Cq); 130.7,
129.3, 129.0, 128.9, 128.6, 128.0, 127.6, 126.6, 126.5 (9d, 15 arom. CH); 121.0 (d, C=CH); 53.2, 52.0 (2q,
2 MeO); 48.7 (t, CH2). CI-MS (m/z): 485 (100, [M+l]+), 425 (5, ([M+l]–MeOCO)+), 344 (18), 342 (74,
([M+l]–MeOCOC=CHCOOMe)+). Anal. Calcd for C28H24N2O4S (484.41): C 69.43, H 4.36, N 5.78;
found: C 69.30, H 4.84, N 5.77.
(Z)-2-[(1,5-Dimethyl-4-phenyl-1H-imidazol-2-y)lsulfanyl]but-2-enedioic acid dimethyl es ter (4c).
Yield: 550 mg (79%). Yel low crys tals, m.p. 113–115°C. IR (KBr): 2950m, 1730vs (C=O), 1710vs (C=O),
1600s, 1430s, 1320vs, 1260vs, 1205vs, 1195vs, 1050m, 1010s. 1H-NMR: 7.59–7.21 (m, 5 arom. H); 6.43 (s, 
C=CH), 3.75, 3.61 (2s, 2 MeO); 3.45 (s, MeN); 2.36 (s, Me). 13C-NMR: 165.4, 164.3 (2s, 2 CO); 147.8 (s,
C=CH); 139.4 (s, imidazole Cq); 134.7 (s, 1 arom. Cq); 128.3, 127.7, 126.9 (3d, 5 arom. CH); 126.5 (s, 2
imidazole Cq); 119.4 (d, C=CH); 53.1, 52.0 (2q, 2 MeO); 31.8 (q, MeN); 10.8 (q, Me). CI-MS (m/z): 347
(100, [M+l]+), 315 (4, ([M+l]–MeO)+). Anal. Calcd for C17H18N2O4S (346.28): C 58.97, H 5.20, N 8.09;
found: C 58.84, H 5.05, N 8.10.
(Z)-2-[(1-Cyclohexyl-4,5-di phen yl-1H-imidazol-2-yl)sulfanyl]but-2-enedioic acid dimethyl es ter
(4d). Yield: 620 mg (65%). Yel low crys tals, m.p. 157–159°C. IR (KBr): 2940m, 2360m, 1730s (C=O),
1710s (C=O), 1590m, 1430m, 1250m, 1200s, 1180s, 1050m, 770m. 1H-NMR: 7.46–7.30, 7.14–7.03 (2m,
10 arom. H); 6.62 (s, C=CH); 3.95 (m, CHN); 3.79, 3.55 (2s, 2 MeO); 2.14–1.13 (m, 5 CH2). 13C-NMR:
165.5, 164.7 (2s, 2 CO); 147.1 (s, C=CH); 138.9 (s, imidazole Cq); 136.8 (s, 2 arom. Cq); 134.0 (s, 2
imidazole Cq); 131.1, 129.0, 128.9, 127.9, 126.3, 126.2 (6d, 10 arom. CH); 120.7 (d, C=CH); 57.5 (d,
CHN); 53.0, 51.9 (2q, 2 MeO); 32.2, 26.0, 24.8 (3t, 5 CH2). CI-MS (m/z): 477 (58, [M+l]+), 438 (7), 336
(24), 335 (100, ([M+1]–DMAD)+), 331 (11), 303 (13), 277 (8), 164 (7). Anal. Calcd for C27H28N2O4S
(476.40): C 68.07, H 5.92, N 5.88; found: C 67.89, H 5.72, N 5.77.
4. Re ac tions of imidazole-2-thiones 1c, g, h with phenylisocyanate. Gen eral pro ce dure. A
solution of phenylisocyanate (238 mg, 2 mmol) in di chloro methane (5 ml) was treated with an equimolar
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amount (2 mmol) of the cor re spond ing imidazole-2-thione 1. The mix ture was kept over night at room tem per -
a ture and next day the sol vent was evap o rated to dry ness. Crude prod ucts were pu ri fied by crys tal li za tion.
3-Benzyl-2,3-dihydro-4,5-dimethyl-2-thioxo-1H-imidazole-1-carboxylic acid N-phenylamide (5a).
Yield: 550 mg (82%). Col or less crys tals, m.p. 156–158°C (hex ane/di chloro methane). IR (KBr): 2930vs,
1730vs (C=O), 1605vs, 1550vs, 1420vs, 1345vs, 1260vs, 1240vs, 750m, 740m, 700s. 1H-NMR: 12.80 (s,
NH); 7.66–7.62, 7.39–7.11 (2m, 10 arom. H); 5.39 (s, CH2); 2.43, 1.98 (2s, 2 Me). 13C-NMR: 161.7 (s,
C=S); 148.8 (s, C=O); 137.1, 135.1 (2s, 2 arom. Cq); 129.0, 128.8, 127.8, 126.7, 120.5 (5d, 10 arom. CH);
123.5, 122.9 (2s, 2 imidazole Cq); 48.3 (t, CH2); 12.7, 9.0 (2q, 2 Me). CI-MS (m/z): 338 (4, [M+1]+), 219 (100,
([M+1]–PhNCO)+), 218 (9). Anal. Calcd for C19H19N3OS (337.32): C 67.65, H 5.64, N 12.46; found: C
67.29, H 5.63, N 12.23.
3-Cyclohexyl-2,3-dihydro-4,5-dimethyl-2-thioxo-1H-imidazole-1-carboxylic acid N-phenylamide
(5b). Yield: 450 mg (69%). Col or less crys tals, m.p. 116–118°C (hex ane/di chloro methane). IR (KBr):
2930s, 2865m, 1730vs (C=O), 1600vs, 1550vs, 1450s, 1380vs, 1235s, 1090m, 770s. 1H-NMR: 7.64–7.61, 
7.36–7.31, 7.28–7.09 (3m, 5 arom. CH); 5.34 (m, CHN); 2.37, 2.20 (2s, 2 Me); 1.95–1.71, 1.47–1.16 (2m, 5
CH2). 13C-NMR: 160.4 (s, C=S); 148.7 (s, C=O); 137.2 (s, arom. Cq); 128.9, 124.5, 120.4 (3d, 5 arom.
CH); 123.7, 122.7 (2s, 2 imidazole Cq); 57.7 (d, CHN); 30.5, 26.1, 25.3 (3t, 5 CH2); 12.3, 10.6 (2q, 2 Me).
CI-MS (m/z): 211 (100, ([M+l]–PhNCO)+). Anal. Calcd for C18H23N3OS (329.31): C 65.65, H 6.99, N
12.76; found: C 65.64, H 6.96, N 12.71.
3-Ethyl-2,3-dihydro-4,5-dimethyl-2-thioxo-1H-imidazole-1-carboxylic acid N-phenylamide (5c).
Yield: 410 mg (75%). Col or less crys tals, m.p. 115–117°C (MeOH). IR (KBr): 2930vs, 1730vs (C=O),
1600vs, 1550vs, 1500m, 1440vs, 1010s, 760s. 1H-NMR: 7.65–7.31, 7.16–7.11 (2m, 5 arom. H); 4.13 (q, J
= 7.2 Hz, CH2); 2.43, 2.12 (2s, 2 Me); 1.31 (t, J = 7.2 Hz, Me). 13C-NMR: 160.0 (s, C=S); 148.8 (s, C=O);
137.2, 123.2, 122.1 (3s, 2 imidazole Cq, 1 arom. Cq); 128.9, 124,5, 120.4 (3d, 5 arom. CH); 40.1 (t, CH2);
13.0, 12.7, 8.6 (3q, 3 Me). CI-MS (m/z): 276 (27, [M+1]+), 158 (7), 157 (100, ([M+1]–PhNCO)+). Anal.
Calcd for C14H17N3OS (275.26): C 61.06, H 6.18, N 15.27; found: C 60.70, H 6.18, N 14.82.
5. X-ray crys tal struc ture de ter mi na tion of 4d and 5b (see Ta ble 1 and Figs. 1–2)*. All mea sure -
ments were made on a Nonius KappaCCD diffractometer [18] us ing graph ite-monochromated MoKa ra -
di a tion (l 0.71073 Å) and an Ox ford Cryosystems Cryostream 700 cooler. Data re duc tion was performed
with HKL Denzo and Scalepack [19]. The in ten si ties were cor rected for Lo rentz and po lar iza tion ef fects,
and ab sorp tion cor rec tions based on the multi-scan method [20] were ap plied.  Equiv a lent re flec tions,
other than Friedel pairs in the case of 5b, were merged. Data col lec tion and re fine ment pa ram e ters are
given in Ta ble 1, and views of the mol e cules are shown in Figs. 1 and 2. The struc tures of 4d and 5b were
solved by di rect meth ods us ing SIR92 [21], which re vealed the po si tions of all non-H-at oms. In the case of 
4d, there are two sym me try-in de pend ent mol e cules in the asym met ric unit. The atomic co or di nates of the
two mol e cules were tested care fully for a re la tion ship from a higher sym me try space group us ing the pro -
gram PLATON [22], but none could be found. The non-H-at oms of 4d and 5b were re fined aniso -
tropically. The am ide H-atom of 5b was placed in the po si tion in di cated by a dif fer ence elec tron den sity
map and its po si tion was al lowed to re fine to gether with an iso tro pic dis place ment pa ram e ter. All re main -
ing H-at oms of 5b and all H-at oms of 4d were placed in geo met ri cally cal cu lated po si tions and re fined us -
ing a rid ing model where each H-atom was as signed a fixed iso tro pic dis place ment pa ram e ter with a value
equal to 1.2Ueq of its par ent C-atom (1.5Ueq for the Me groups). The re fine ment of each struc ture was car -
ried out on F2 us ing full-ma trix least-squares pro ce dures, which min i mized the func tion Sw(Fo2–Fc2)2.
Cor rec tions for sec ond ary ex tinc tion were ap plied for 4d and 5b. In the case of 4d, three re flec tions,
whose in ten si ties were con sid ered to be ex treme out li ers, were omit ted from the fi nal re fine ment. Re fine -
ment of the ab so lute struc ture pa ram e ter [23] of 5b yielded a value of –0.02(7), which con fi dently con -
firms that the re fined model cor re sponds with the true ab so lute struc ture. Neu tral atom scat ter ing fac tors
for non-H-at oms were taken from [24a], and the scat ter ing fac tors for H-at oms were taken from [25].
Anom a lous dis per sion ef fects were in cluded in Fc [26]; the val ues for f ¢ and f ¢¢were those of [24b]. The
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* CCDC-683042–683043 contain the supplementary crystallographic data for this paper.
These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via
www. ccdc.cam.ac.uk./data_request/cif.
val ues of the mass at ten u a tion co ef fi cients are those of [24c]. All cal cu la tions were per formed us ing the
SHELXL97 [27] pro gram.
Ta ble 1. Crys tal lo graphic data for com pounds 4d and 5b.
4d 5b
Crys tal lized from PrOH MeOH
Em pir i cal for mula C27H28N2O4S C18H23N3OS
For mula weight [g mol–1] 476.59 329.46
Crys tal color, habit yel low, tab let col or less, nee dle
Crys tal di men sions [mm] 0.10 × 0.20 × 0.25 0.05 × 0.08 × 0.28
Tem per a ture [K] 160(1) 160(1)
Crys tal sys tem monoclinic orthorhombic
Space group P21/c P212121
Z 8 4
Re flec tions for cell de ter mi na tion 60273 73067
2q range for cell de ter mi na tion [°] 4–50 4–50
Unit cell pa ram e ters a [Å] 10.4802(1) 8.1195(1)
                                 b [Å] 23.2343(4) 10.4415(2)
                                 c [Å] 20.4449(3) 20.3333(3)
                                 b [°] 101.794(1) 90
                                 V [Å3] 4873.2(1) 1723.85(5)
Dx [g cm
–3] 1.299 1.269
m(MoKa) [mm–1] 0.169 0.196
Scan type f and w f and w
2q(max) [°] 50 50
Trans mis sion fac tors (min; max) 0.898; 0.985 0.861; 0.991
To tal re flec tions mea sured 91589 23929
Sym me try in de pend ent re flec tions 8607 3041
Re flec tions with I > 2s (I) 6458 2804
Re flec tions used in re fine ment 8604 3041
Pa ram e ters re fined 618 215
Fi nal R(F) [I >2s (I) re flec tions] 0.0441 0.0286
         wR(F2)  (all data) 0.1092 0.0696
Weights:a) a; b 0.0467; 2.3771 0.0351; 0.3110
Good ness of fit 1.032 1.047
Sec ond ary ex tinc tion co ef fi cient 0.0020(3) 0.013(1)
Fi nal Dmax/s 0.001 0.002
Dr (max; min) [e Å–3] 0.61; –0.41 0.16; –0.17
a)w = [s2(Fo2) + (aP)2 + bP]–1, where P = (Fo2 + 2Fc2)/3
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